Biktarvy Prescription Discount Coupon

Life happens. When it does, you may need help with your medicine or co-pay costs. Many drug manufactor provide drug coupon to help with medication.

Biktarvy Coupon Details

Biktarvy Advancing Access Co-pay Program: Eligible commercially insured patients may save up to a maximum of $7200 per year with no monthly limits; for additional information contact the program at 800-226-2056.

Benefits :

  • Prescription
  • Offer Type: Copay Card Program
  • Activate By: Patient
  • Coverage Requirments:
  • Pharmacy Support Number 800-226-2056

Contact Details :

Free Discount Drug Coupon

All patients are eligible to receive a discount by using this free Biktarvy coupon. Save up to 80% on your prescription costs when using our drug coupons at your local pharmacy.

Assistance Fund - Financial Assistance
Assistance Fund - Financial Assistance

Free Prescription Discount Card

  • No registration required.
  • Everyone is eligible.
  • Get discount up to 80%.
  • Card can be used for person with Insurance or without insurance for discount.
  • Never expires.
  • Ready for immediate.
  • No activation required.
  • Prescription Coupon

Biktarvy Cost

How much does Biktarvy cost near you?

It may varies based on the pharmacy you fill you prescription from.

Biktarvy Copay Assistance

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Elligibility requirements:

  • 1. Must be uninsured.
  • 2. At or below 400% of FPL.
  • 3. Must reside and receive treatment in US.
  • 4. Biktarvy Copay assistance, and patient assistance programs are available for eligible patients.

Programs

Advancing Access Program

This program provides brand name medications at no or low cost

Provider: Gilead Sciences, Inc.

Medication :



  • Biktarvy tablet (bictegravir-emtricitabine-tenofovir alafenamide)

Additional Info for Coupon

This program is for outpatient use only.

Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.

This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs.

IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company.

Coupon Eligibility

Insurance: Must be uninsured or underinsured

Income: At or below 500% of FPL

US Residency: Must be residing in the US or Puerto Rico

Part D: Contact program for details.

Diagnosis: Medically appropriate condition/diagnosis

Good Days Program

This is a copay assistance program

Provider: Good Days from CDF

Medication :



  • Biktarvy tablet (bictegravir-emtricitabine-tenofovir alafenamide)

Additional Info for Coupon

Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Coupon Eligibility

Insurance: Must have insurance

Income: At or below 500% of FPL

US Residency: Yes and have social security number

Part D: Not specified

Diagnosis: FDA-approved diagnosis

Patient Access Network Foundation (PAN)

This is a copay assistance program

Provider: Patient Access Network Foundation

Medication :



  • Biktarvy tablet (bictegravir-emtricitabine-tenofovir alafenamide)

Additional Info for Coupon

*Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.

Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Coupon Eligibility

Insurance: *See Additional Information section below

Income: Between 400-500% of FPL

US Residency: Must reside and receive treatment in US

Part D: Determined case by case

Diagnosis: FDA Approved Diagnosis - See Program Website for Details